![Lori Houle](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profiel
Lori Houle worked at Dermira, Inc. as Head-Quality from 2014 to 2017.
Then worked at Vir Biotechnology, Inc. as Vice President-Global Quality from 2017 to 2021.
Later worked at Neumora Therapeutics, Inc. as Senior Vice President-Quality from 2021 to 2022.
Education includes an MBA from DeVry University and an undergraduate degree from the University of Wisconsin.
Eerdere bekende functies van Lori Houle
| Bedrijven | Functie | Einde |
|---|---|---|
| VIR BIOTECHNOLOGY, INC. | Corporate Officer/Principal | 01-04-2021 |
| DERMIRA, INC. | Corporate Officer/Principal | 01-10-2017 |
| NEUMORA THERAPEUTICS, INC. | Hoofd Techniek/Wetenschap/O&O | - |
Opleiding van Lori Houle
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
20
Eerstegraads connecties
5
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 5 |
|---|---|
DeVry University
 DeVry University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Wisconsin
 University of Wisconsin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Dermira, Inc.
 Dermira, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products to patients living with chronic skin conditions | Health Technology |
Vir Biotechnology, Inc.
 Vir Biotechnology, Inc. BiotechnologyHealth Technology Develops cures and treatments drug for viral & bacterial diseases | Health Technology |
Neumora Therapeutics, Inc.
 Neumora Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company which develops medicines for brain diseases | Health Technology |
